img

Global Rituximab Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Rituximab Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Rituximab is a type of antibody therapy that can be used alone or with chemotherapy.
Rituximab report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Rituximab market is projected to reach US$ 6006.3 million in 2029, increasing from US$ 10350 million in 2022, with the CAGR of -5.2% during the period of 2024 to 2029. Demand from Intravenous Use and Subcutaneous Use are the major drivers for the industry.
Revlimid, an oral medication used in the treatment of multiple myeloma and other blood cancers, is experiencing increasing demand. Factors driving market growth include the rising incidence of blood cancers, advancements in treatment options, and the expanding geriatric population. Key players in the market are focusing on expanding the indications of Revlimid and conducting clinical trials for new indications. Additionally, strategic collaborations and mergers are contributing to market expansion. However, challenges such as patent expirations and the availability of generic alternatives may impact market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Rituximab market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Roche
Pfizer
Biogen
Teva
Segment by Type
500mg
100mg

Segment by Application


Intravenous Use
Subcutaneous Use

Segment by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Rituximab market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Rituximab, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Rituximab industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Rituximab in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Rituximab introduction, etc. Rituximab Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Rituximab market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Rituximab Market Overview
1.1 Rituximab Product Overview
1.2 Rituximab Market Segment by Type
1.2.1 500mg
1.2.2 100mg
1.3 Global Rituximab Market Size by Type
1.3.1 Global Rituximab Market Size Overview by Type (2018-2029)
1.3.2 Global Rituximab Historic Market Size Review by Type (2018-2024)
1.3.3 Global Rituximab Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Rituximab Sales Breakdown by Type (2018-2024)
1.4.2 Europe Rituximab Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Rituximab Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Rituximab Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Rituximab Sales Breakdown by Type (2018-2024)
2 Global Rituximab Market Competition by Company
2.1 Global Top Players by Rituximab Sales (2018-2024)
2.2 Global Top Players by Rituximab Revenue (2018-2024)
2.3 Global Top Players by Rituximab Price (2018-2024)
2.4 Global Top Manufacturers Rituximab Manufacturing Base Distribution, Sales Area, Product Type
2.5 Rituximab Market Competitive Situation and Trends
2.5.1 Rituximab Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Rituximab Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rituximab as of 2022)
2.7 Date of Key Manufacturers Enter into Rituximab Market
2.8 Key Manufacturers Rituximab Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Rituximab Status and Outlook by Region
3.1 Global Rituximab Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Rituximab Historic Market Size by Region
3.2.1 Global Rituximab Sales in Volume by Region (2018-2024)
3.2.2 Global Rituximab Sales in Value by Region (2018-2024)
3.2.3 Global Rituximab Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Rituximab Forecasted Market Size by Region
3.3.1 Global Rituximab Sales in Volume by Region (2024-2029)
3.3.2 Global Rituximab Sales in Value by Region (2024-2029)
3.3.3 Global Rituximab Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Rituximab by Application
4.1 Rituximab Market Segment by Application
4.1.1 Intravenous Use
4.1.2 Subcutaneous Use
4.2 Global Rituximab Market Size by Application
4.2.1 Global Rituximab Market Size Overview by Application (2018-2029)
4.2.2 Global Rituximab Historic Market Size Review by Application (2018-2024)
4.2.3 Global Rituximab Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Rituximab Sales Breakdown by Application (2018-2024)
4.3.2 Europe Rituximab Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Rituximab Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Rituximab Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Rituximab Sales Breakdown by Application (2018-2024)
5 North America Rituximab by Country
5.1 North America Rituximab Historic Market Size by Country
5.1.1 North America Rituximab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Rituximab Sales in Volume by Country (2018-2024)
5.1.3 North America Rituximab Sales in Value by Country (2018-2024)
5.2 North America Rituximab Forecasted Market Size by Country
5.2.1 North America Rituximab Sales in Volume by Country (2024-2029)
5.2.2 North America Rituximab Sales in Value by Country (2024-2029)
6 Europe Rituximab by Country
6.1 Europe Rituximab Historic Market Size by Country
6.1.1 Europe Rituximab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Rituximab Sales in Volume by Country (2018-2024)
6.1.3 Europe Rituximab Sales in Value by Country (2018-2024)
6.2 Europe Rituximab Forecasted Market Size by Country
6.2.1 Europe Rituximab Sales in Volume by Country (2024-2029)
6.2.2 Europe Rituximab Sales in Value by Country (2024-2029)
7 Asia-Pacific Rituximab by Region
7.1 Asia-Pacific Rituximab Historic Market Size by Region
7.1.1 Asia-Pacific Rituximab Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Rituximab Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Rituximab Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Rituximab Forecasted Market Size by Region
7.2.1 Asia-Pacific Rituximab Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Rituximab Sales in Value by Region (2024-2029)
8 Latin America Rituximab by Country
8.1 Latin America Rituximab Historic Market Size by Country
8.1.1 Latin America Rituximab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Rituximab Sales in Volume by Country (2018-2024)
8.1.3 Latin America Rituximab Sales in Value by Country (2018-2024)
8.2 Latin America Rituximab Forecasted Market Size by Country
8.2.1 Latin America Rituximab Sales in Volume by Country (2024-2029)
8.2.2 Latin America Rituximab Sales in Value by Country (2024-2029)
9 Middle East and Africa Rituximab by Country
9.1 Middle East and Africa Rituximab Historic Market Size by Country
9.1.1 Middle East and Africa Rituximab Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Rituximab Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Rituximab Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Rituximab Forecasted Market Size by Country
9.2.1 Middle East and Africa Rituximab Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Rituximab Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Roche
10.1.1 Roche Company Information
10.1.2 Roche Introduction and Business Overview
10.1.3 Roche Rituximab Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Roche Rituximab Products Offered
10.1.5 Roche Recent Development
10.2 Pfizer
10.2.1 Pfizer Company Information
10.2.2 Pfizer Introduction and Business Overview
10.2.3 Pfizer Rituximab Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Pfizer Rituximab Products Offered
10.2.5 Pfizer Recent Development
10.3 Biogen
10.3.1 Biogen Company Information
10.3.2 Biogen Introduction and Business Overview
10.3.3 Biogen Rituximab Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Biogen Rituximab Products Offered
10.3.5 Biogen Recent Development
10.4 Teva
10.4.1 Teva Company Information
10.4.2 Teva Introduction and Business Overview
10.4.3 Teva Rituximab Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Teva Rituximab Products Offered
10.4.5 Teva Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Rituximab Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Rituximab Industrial Chain Analysis
11.4 Rituximab Market Dynamics
11.4.1 Rituximab Industry Trends
11.4.2 Rituximab Market Drivers
11.4.3 Rituximab Market Challenges
11.4.4 Rituximab Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Rituximab Distributors
12.3 Rituximab Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of 500mg
Table 2. Major Company of 100mg
Table 3. Global Rituximab Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Rituximab Sales by Type (2018-2024) & (K Units)
Table 5. Global Rituximab Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Rituximab Sales by Type (2018-2024) & (US& Million)
Table 7. Global Rituximab Market Share in Value by Type (2018-2024)
Table 8. Global Rituximab Price by Type (2018-2024) & (USD/Unit)
Table 9. Global Rituximab Sales by Type (2024-2029) & (K Units)
Table 10. Global Rituximab Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Rituximab Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Rituximab Sales Market Share in Value by Type (2024-2029)
Table 13. Global Rituximab Price by Type (2024-2029) & (USD/Unit)
Table 14. North America Rituximab Sales by Type (2018-2024) & (K Units)
Table 15. North America Rituximab Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Rituximab Sales (K Units) by Type (2018-2024)
Table 17. Europe Rituximab Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Rituximab Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Rituximab Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Rituximab Sales (K Units) by Type (2018-2024)
Table 21. Latin America Rituximab Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Rituximab Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Rituximab Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Rituximab Sales by Company (2018-2024) & (K Units)
Table 25. Global Rituximab Sales Share by Company (2018-2024)
Table 26. Global Rituximab Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Rituximab Revenue Share by Company (2018-2024)
Table 28. Global Market Rituximab Price by Company (2018-2024) & (USD/Unit)
Table 29. Global Rituximab Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Rituximab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Rituximab as of 2022)
Table 32. Date of Key Manufacturers Enter into Rituximab Market
Table 33. Key Manufacturers Rituximab Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Rituximab Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Rituximab Sales by Region (2018-2024) & (K Units)
Table 37. Global Rituximab Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Rituximab Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Rituximab Sales Market Share in Value by Region (2018-2024)
Table 40. Global Rituximab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 41. Global Rituximab Sales by Region (2024-2029) & (K Units)
Table 42. Global Rituximab Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Rituximab Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Rituximab Sales Market Share in Value by Region (2024-2029)
Table 45. Global Rituximab Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
Table 46. Global Rituximab Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Rituximab Sales by Application (2018-2024) & (K Units)
Table 48. Global Rituximab Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Rituximab Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Rituximab Sales Market Share in Value by Application (2018-2024)
Table 51. Global Rituximab Price by Application (2018-2024) & (USD/Unit)
Table 52. Global Rituximab Sales by Application (2024-2029) & (K Units)
Table 53. Global Rituximab Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Rituximab Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Rituximab Sales Market Share in Value by Application (2024-2029)
Table 56. Global Rituximab Price by Application (2024-2029) & (USD/Unit)
Table 57. North America Rituximab Sales by Application (2018-2024) (K Units)
Table 58. North America Rituximab Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Rituximab Sales by Application (2018-2024) (K Units)
Table 60. Europe Rituximab Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Rituximab Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Rituximab Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Rituximab Sales by Application (2018-2024) (K Units)
Table 64. Latin America Rituximab Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Rituximab Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Rituximab Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Rituximab Sales by Country (2018-2024) & (K Units)
Table 68. North America Rituximab Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Rituximab Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Rituximab Sales Market Share in Value by Country (2018-2024)
Table 71. North America Rituximab Sales by Country (2024-2029) & (K Units)
Table 72. North America Rituximab Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Rituximab Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Rituximab Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Rituximab Sales by Country (2018-2024) & (K Units)
Table 76. Europe Rituximab Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Rituximab Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Rituximab Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Rituximab Sales by Country (2024-2029) & (K Units)
Table 80. Europe Rituximab Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Rituximab Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Rituximab Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Rituximab Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Rituximab Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Rituximab Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Rituximab Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Rituximab Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Rituximab Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Rituximab Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Rituximab Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Rituximab Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Rituximab Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Rituximab Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Rituximab Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Rituximab Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Rituximab Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Rituximab Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Rituximab Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Rituximab Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Rituximab Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Rituximab Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Rituximab Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Rituximab Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Rituximab Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Rituximab Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Rituximab Sales Market Share in Value by Country (2024-2029)
Table 107. Roche Company Information
Table 108. Roche Introduction and Business Overview
Table 109. Roche Rituximab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Roche Rituximab Product
Table 111. Roche Recent Development
Table 112. Pfizer Company Information
Table 113. Pfizer Introduction and Business Overview
Table 114. Pfizer Rituximab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Pfizer Rituximab Product
Table 116. Pfizer Recent Development
Table 117. Biogen Company Information
Table 118. Biogen Introduction and Business Overview
Table 119. Biogen Rituximab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Biogen Rituximab Product
Table 121. Biogen Recent Development
Table 122. Teva Company Information
Table 123. Teva Introduction and Business Overview
Table 124. Teva Rituximab Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Teva Rituximab Product
Table 126. Teva Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Rituximab Market Trends
Table 130. Rituximab Market Drivers
Table 131. Rituximab Market Challenges
Table 132. Rituximab Market Restraints
Table 133. Rituximab Distributors List
Table 134. Rituximab Downstream Customers
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Rituximab Product Picture
Figure 2. Global Rituximab Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Rituximab Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Rituximab Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of 500mg
Figure 6. Global 500mg Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of 100mg
Figure 8. Global 100mg Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Rituximab Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Rituximab Sales Market Share by Type in 2022 & 2029
Figure 11. North America Rituximab Sales Market Share in Volume by Type in 2022
Figure 12. North America Rituximab Sales Market Share in Value by Type in 2022
Figure 13. Europe Rituximab Sales Market Share in Volume by Type in 2022
Figure 14. Europe Rituximab Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Rituximab Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Rituximab Sales Market Share in Value by Type in 2022
Figure 17. Latin America Rituximab Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Rituximab Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Rituximab Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Rituximab Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Rituximab Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Rituximab Revenue in 2022
Figure 23. Rituximab Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Intravenous Use
Figure 25. Global Intravenous Use Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Subcutaneous Use
Figure 27. Global Subcutaneous Use Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Global Rituximab Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Rituximab Sales Market Share by Application in 2022 & 2029
Figure 30. North America Rituximab Sales Market Share in Volume by Application in 2022
Figure 31. North America Rituximab Sales Market Share in Value by Application in 2022
Figure 32. Europe Rituximab Sales Market Share in Volume by Application in 2022
Figure 33. Europe Rituximab Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Rituximab Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Rituximab Sales Market Share in Value by Application in 2022
Figure 36. Latin America Rituximab Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Rituximab Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Rituximab Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Rituximab Manufacturing Cost Structure
Figure 41. Rituximab Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed